Vertex Pharmaceuticals

Antibiotics and Infectious diseasesRespiratory and Pulmonary

Vertex Pharmaceuticals

US biotech firm Vertex Pharmaceuticals is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.

US biotech firm Vertex Pharmaceuticals (Nasdaq: VRTX) is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.

In May 2011, the US Food and Drug Administration (FDA) approved Vertex’s first medicine, Incivek (telaprevir) a treatment for hepatitis C. In January 2012, Vertex received FDA approval for its cystic fibrosis drug. Vertex received European approval of Kalydeco (ivacaftor) for cystic fibrosis in July 2012.

In addition to its approved medicines, it is developing new combinations of medicines that could further advance treatment of hepatitis C and cystic fibrosis as well as a broad pipeline of other potential new medicines currently in early and mid-stage development for diseases such as rheumatoid arthritis, influenza and other diseases.


Latest Articles

Latest News

Who's Who

Back to top